全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

Degenerative Neurological and Neuromuscular Disease

ISSN Print: 1179-9900

ISSN Online:

主页: https://www.dovepress.com/degenerative-neurological-and-neuromuscular-disease-journal

分享:




Go

The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease

Walsh B, Slater S, Nair B, Attia J

The pharmacologic management of depression in Parkinson's disease

Schreiber MA, Thompson AW

The pharmacologic management of depression in Parkinson's disease

Schreiber MA,Thompson AW

The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease

Walsh B,Slater S,Nair B,Attia J

Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy

Buxbaum JN

Inclusion body myositis: therapeutic approaches

Aggarwal R, Oddis CV

Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets

Henney III HR, Blight AR

Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease

Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Groover CJ

Update on pediatric dystonias: etiology, epidemiology, and management

Fernández-Alvarez E, Nardocci N

New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience

Suhr OB, Gustavsson S, Heldestad V, H rnsten R, Lindqvist P, Nordh E, Wiklund U

Cell adhesion molecules in Alzheimer's disease

Wennstr m M, Nielsen HM

Stem cells and regenerative therapies for Parkinson’s disease

Farrell K, Barker RA

Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safety

Pouratian N, Thakkar S, Kim W, Bronstein JM

Optimal management for people with severe spasticity

Shilt JS, Seibert PS, Kadyan V

Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis

Nwankwo E, Allington DR, Rivey MP

BG-12 and its potential for the prevention of relapse in multiple sclerosis

Giannetti P, Niccolini F, Nicholas R

Amyotrophic lateral sclerosis: update and new developments

Pratt AJ, Getzoff ED, Perry JJ

Recent advances in Duchenne muscular dystrophy

Perkins KJ, Davies KE

Recent advances in Duchenne muscular dystrophy

Perkins KJ,Davies KE

Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease

Levin MC,Lee S,Gardner LA,Shin Y

Stem cells and regenerative therapies for Parkinson’s disease

Farrell K,Barker RA

Cell adhesion molecules in Alzheimer's disease

Wennström M,Nielsen HM

Amyotrophic lateral sclerosis: update and new developments

Pratt AJ,Getzoff ED,Perry JJ

Update on pediatric dystonias: etiology, epidemiology, and management

Fernández-Alvarez E,Nardocci N

Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis

Nwankwo E,Allington DR,Rivey MP

Optimal management for people with severe spasticity

Shilt JS,Seibert PS,Kadyan V

Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safety

Pouratian N,Thakkar S,Kim W,Bronstein JM

New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience

Suhr OB,Gustavsson S,Heldestad V,Hörnsten R

BG-12 and its potential for the prevention of relapse in multiple sclerosis

Giannetti P,Niccolini F,Nicholas R

Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets

Henney III HR,Blight AR

Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy

Buxbaum JN

Inclusion body myositis: therapeutic approaches

Aggarwal R,Oddis CV

Editorial

Glenn Lopate

Therapeutic application of monoclonal antibodies in multiple sclerosis: focus on alemtuzumab

Niino M

Critical appraisal and role of memantine extended-release in the management of Alzheimer’s disease

Singh I, Grossberg GT

Evaluation of glycopyrrolate in the treatment of chronic drooling

Reddihough DS, Reid SM, Plover C

Profile of oral laquinimod and its potential in the treatment of multiple sclerosis

West MS, Miravalle A

Emerging treatment options for spasticity in multiple sclerosis – clinical utility of cannabinoids

Ashton JC

Editorial

Glenn Lopate

Therapeutic application of monoclonal antibodies in multiple sclerosis: focus on alemtuzumab

Niino M

Profile of oral laquinimod and its potential in the treatment of multiple sclerosis

West MS,Miravalle A

Evaluation of glycopyrrolate in the treatment of chronic drooling

Reddihough DS,Reid SM,Plover C

Emerging treatment options for spasticity in multiple sclerosis – clinical utility of cannabinoids

Ashton JC

Critical appraisal and role of memantine extended-release in the management of Alzheimer’s disease

Singh I,Grossberg GT

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705